2016
DOI: 10.1039/c5ob02129d
|View full text |Cite
|
Sign up to set email alerts
|

A protocol for amide bond formation with electron deficient amines and sterically hindered substrates

Abstract: A protocol for amide coupling by in situ formation of acyl fluorides and reaction with amines at elevated temperature has been developed and found to be efficient for coupling of sterically hindered substrates and electron deficient amines where standard methods failed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
56
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 83 publications
(56 citation statements)
references
References 29 publications
0
56
0
Order By: Relevance
“…The reactions with N‐( 3‐dimethylaminopropyl)‐ N ′‐ethylcarbodiimide hydrochloride (EDC), N , N , N′ , N′ ‐tetramethyl‐ O ‐(1 H ‐benzotriazol‐1‐yl)uronium hexafluorophosphate (HBTU), and N ‐ethoxycarbonyl‐2‐ethoxy‐1,2‐dihydroquinoline (EEDQ) as coupling agents failed to improve the reaction output . Finally, we decided to adopt the procedure of Ulven and co‐workers; the use of chlorodipyrrolidinocarbenium hexafluorophosphate (PyClU) as the coupling reagent allowed us to isolate CoumDimer . The first reaction was performed in ethylene chloride, but the yield was not satisfactory (21 %).…”
Section: Resultsmentioning
confidence: 99%
“…The reactions with N‐( 3‐dimethylaminopropyl)‐ N ′‐ethylcarbodiimide hydrochloride (EDC), N , N , N′ , N′ ‐tetramethyl‐ O ‐(1 H ‐benzotriazol‐1‐yl)uronium hexafluorophosphate (HBTU), and N ‐ethoxycarbonyl‐2‐ethoxy‐1,2‐dihydroquinoline (EEDQ) as coupling agents failed to improve the reaction output . Finally, we decided to adopt the procedure of Ulven and co‐workers; the use of chlorodipyrrolidinocarbenium hexafluorophosphate (PyClU) as the coupling reagent allowed us to isolate CoumDimer . The first reaction was performed in ethylene chloride, but the yield was not satisfactory (21 %).…”
Section: Resultsmentioning
confidence: 99%
“…The allosteric FFA2R modulator AZ1729 (Bolognini et al, 2016) was a generous gift from AstraZeneca (Mölndal, Sweden) and the phenylacetamide compound (S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-phenylthiazol-2-yl)butanamide (PA;Cmp58 (Wang et al, 2010)) was obtained from Calbiochem-Merck Millipore (Billerica, USA) The Gαq inhibitor YM-254890 was purchased from Wako Chemicals (Neuss, Germany). The FFA2R antagonist CATPB ((S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trifluoromethyl)-phenyl) butanoic acid) synthesized as described previously (Due-Hansen et al, 2015; Hudson et al, 2013; Hudson et al, 2012), was a generous gift from Trond Ulven (Odense university, Denmark). The P2Y 2 R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5 H -dibenzo[ a , d ]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2 H )-pyrimidinyl]methyl]- N -2 H -tetrazol-5-yl-2-furancarboxamide) was obtained from Tocris (Abingdon, UK).…”
Section: Methodsmentioning
confidence: 99%
“…Compound 1 was synthesized as described previously (54). 4-CMTB was synthesized as described previously (18).…”
Section: Methodsmentioning
confidence: 99%